文献速递细菌感染、耐药与抗菌药物医院感染防控

发热性中性粒细胞减少症患者血培养当前阳性时间:可用于抗菌药物管理降阶梯策略的工具

Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
PubMed 文献 · Clin Microbiol Infect · 2018-08-07

该研究前瞻性收集2003至2017年肿瘤血液病患者发热性中性粒细胞减少症的血流感染发作,描述血培养阳性时间(TTP)。850例独特发作中,92.1%的血培养在24小时内阳性,所有耐多药革兰阴性杆菌(MDR-GNB)血流感染均在24小时内阳性。结果支持在24小时重新评估中性粒细胞减少患者的经验性抗生素治疗以实施降阶梯策略。

要点

  • 850例发作中,92.1%(783/850)血培养在24小时内阳性,中位TTP为12小时。
  • 126例(14.8%)为MDR-GNB血流感染,无一例TTP超过24小时。
  • 67例(7.9%)TTP≥24小时,其中25例(37.3%)已接受针对分离病原体的活性抗生素治疗。

核心结论

  • 当前肿瘤血液病合并发热性中性粒细胞减少症患者的血流感染绝大多数TTP小于24小时,包括所有MDR-GNB引起的发作。
  • 结果支持在24小时重新评估中性粒细胞减少患者的经验性抗生素治疗,以应用抗菌药物管理降阶梯策略。

研究设计与样本

  • 前瞻性收集2003至2017年肿瘤血液病患者发热性中性粒细胞减少症的血流感染发作。
  • 同一患者多次血流感染时随机选择一次发作,共纳入850例独特发作。
  • 记录从开始孵育到首次阳性读数的时间,以第一瓶阳性作为TTP记录点。

主要发现

  • 850例发作中,323例(38%)为急性白血病,185例(21.8%)为非霍奇金淋巴瘤,144例(16.9%)为实体肿瘤。
  • 最常见分离病原体为凝固酶阴性葡萄球菌225例(26.5%)、大肠埃希菌207例(26.1%)、铜绿假单胞菌136例(16%)、肠球菌属81例(9.5%)和肺炎克雷伯菌67例(7.9%)。
  • MDR-GNB记录于126例(14.8%)发作,中位TTP为12小时(四分位距9-16.5小时)。
  • 24小时内92.1%(783/850)血培养阳性,无MDR-GNB在24小时后阳性。
  • 67例(7.9%)TTP≥24小时,其中25例(37.3%)已接受针对分离病原体的活性抗生素治疗;常见分离菌为凝固酶阴性葡萄球菌、念珠菌血症和一组厌氧革兰阴性杆菌。

临床怎么用

  • 作者认为结果支持在24小时重新评估中性粒细胞减少患者的经验性抗生素治疗,以应用抗菌药物管理降阶梯策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to describe the current time-to-positivity (TTP) of blood cultures in individuals with onco-haematological diseases with febrile neutropenia. We assessed the probability of having a multidrug-resistant Gram-negative bacilli (MDR-GNB) bloodstream infection (BSI) 24 h after cultures were taken, to use this information for antibiotic de-escalation strategies. METHODS: BSI episodes were prospectively collected (2003-2017). When a patient experienced more than one BSI, only one episode was randomly chosen. Time elapsed from the beginning of incubation to a positive reading was observed; TTP was recorded when the first bottle had a positive result. RESULTS: Of the 850 patient-unique episodes, 323 (38%) occurred in acute leukaemia, 185 (21.8%) in non-Hodgkin's lymphoma and 144 (16.9%) in solid neoplasms. Coagulase-negative staphylococci (225; 26.5%), Escherichia coli (207; 26.1%), Pseudomonas aeruginosa (136; 16%), Enterococcus spp. (81; 9.5%) and Klebsiella pneumoniae (67; 7.9%), were the most frequent microorganisms isolated. MDR-GNB were documented in 126 (14.8%) episodes. Median TTP was 12 h (interquartile range 9-16.5 h). Within the first 24 h, 92.1% of blood cultures were positive (783/850). No MDR-GNB was positive over 24 h. Of the 67 (7.9%) episodes with a TTP ≥24 h, 25 (37.3%) occurred in patients who were already receiving active antibiotics against the isolated pathogen. Most common isolations with TTP ≥24 h were coagulase-negative staphylococci, candidaemia and a group of anaerobic GNB. CONCLUSIONS: Currently, the vast majority of BSI in individuals with onco-haematological diseases with febrile neutropenia have a TTP <24 h, including all episodes caused by MDR-GNB. Our results support reassessing empiric antibiotic treatment in neutropenic patients at 24 h, to apply antibiotic stewardship de-escalation strategies.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Puerta-Alcalde P, Cardozo C, Suárez-Lledó M, et al. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies. Clin Microbiol Infect. 2018. PMID: 30096417. doi:10.1016/j.cmi.2018.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。